While we did observe an increase of ASCT2 expression in both serous and endometrioid subtypes of endometrial cancer, we did not observe a correlation between ASCT2 mRNA expression level and clinical outcome in analysis of the TCGA cohort. The gene discussed is SLC1A5; the disease is endometrial cancer.